<div id="readability-page-1"><p>Walleye Capital LLC lifted its holdings in shares of  Innospec Inc. (NASDAQ:IOSP - Free Report) by 324.5% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 40,120 shares of the specialty chemicals company's stock after acquiring an additional 30,669 shares during the period. Walleye Capital LLC owned approximately 0.16% of Innospec worth $3,374,000 at the end of the most recent quarter.</p><p>Other hedge funds and other institutional investors have also recently modified their holdings of the company. Nuveen LLC purchased a new stake in  Innospec during the 1st quarter worth approximately $42,966,000.  Millennium Management LLC increased its position in shares of  Innospec by 8,176.5% in the 1st quarter. Millennium Management LLC now owns 170,414 shares of the specialty chemicals company's stock valued at $16,147,000 after acquiring an additional 168,355 shares during the period.  Norges Bank purchased a new position in  Innospec in the 2nd quarter worth $11,230,000.  Voya Investment Management LLC raised its stake in  Innospec by 63.2% in the 1st quarter. Voya Investment Management LLC now owns 327,289 shares of the specialty chemicals company's stock worth $31,011,000 after acquiring an additional 126,750 shares during the last quarter.  Finally, Jane Street Group LLC lifted its position in  Innospec by 1,551.5% during the 1st quarter. Jane Street Group LLC now owns 95,243 shares of the specialty chemicals company's stock worth $9,024,000 after acquiring an additional 89,476 shares during the period. 96.64% of the stock is owned by hedge funds and other institutional investors. </p><h2>Innospec Trading Up 1.4%</h2><p>NASDAQ IOSP opened at $75.04 on Monday. The stock has a market capitalization of $1.86 billion, a price-to-earnings ratio of -2,501.33 and a beta of 0.93. The stock has a 50-day moving average of $74.74 and a 200 day moving average of $80.92. Innospec Inc. has a twelve month low of $70.10 and a twelve month high of $120.00. </p><p>Innospec (NASDAQ:IOSP - Get Free Report) last released its quarterly earnings results on Wednesday, November 5th. The specialty chemicals company reported $1.12 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.03 by $0.09. The firm had revenue of $441.90 million for the quarter, compared to analysts' expectations of $443.00 million. Innospec had a negative net margin of 0.07% and a positive return on equity of 10.28%. The firm's revenue for the quarter was down .3% compared to the same quarter last year. During the same quarter last year, the company earned $1.35 EPS.  Equities analysts predict that  Innospec Inc. will post 6.18 EPS for the current fiscal year. </p><h2>Innospec Dividend Announcement</h2><p>The business also recently declared a  dividend, which was paid on Wednesday, November 26th. Investors of record on Tuesday, November 18th were paid a $0.87 dividend. The ex-dividend date of this dividend was Tuesday, November 18th. This represents a yield of 245.0%. Innospec's dividend payout ratio (DPR) is currently -5,800.00%. </p><h2>Analysts Set New Price Targets</h2><p>IOSP has been the subject of several research analyst reports. Zacks Research cut Innospec from a &#34;hold&#34; rating to a &#34;strong sell&#34; rating in a research note on Tuesday, November 4th. Wall Street Zen cut shares of Innospec from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research note on Sunday, October 19th. Finally, Weiss Ratings  reiterated a &#34;sell (d)&#34; rating on shares of Innospec in a research note on Thursday. One analyst  has rated the stock with a Strong Buy rating and two have given a Sell rating to the company's stock. According to MarketBeat.com, Innospec currently has a consensus rating of &#34;Hold&#34;.</p><p><b>Check Out Our Latest Analysis on Innospec</b></p><h2>Insider Buying and Selling</h2><p>In other news, Director Leslie J. Parrette bought 340 shares of Innospec stock in a transaction on Friday, November 14th. The stock was acquired at an average price of $74.09 per share, with a total value of $25,190.60. Following the completion of the acquisition, the director directly owned 5,837 shares of the company's stock, valued at $432,463.33. The trade was a 6.19% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through this link. Company insiders own  1.31% of the company's stock. </p><h2>Innospec Company Profile</h2> (Free Report)<p>Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Innospec</li><li>Trading Stocks: RSI and Why it's Useful</li><li>Broadcom’s Biggest Test Yet: Will Q4 Earnings Spark Another Rally?</li><li>How to Invest in Tech Stocks and Top Tech Stocks to Consider</li><li>Rubrik’s Massive Rebound: Why the Next Leg Higher Could Be Fast</li><li>Roth IRA Calculator: Calculate Your Potential Returns</li><li>Five Below and Dollar Tree Earnings Signal a Shopper Shift</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SU9TUA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SU9TUA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Innospec Right Now?</h2><p>Before you consider Innospec, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list.</p><p>While Innospec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

IOSP

<p>Walleye Capital LLC increased its holdings in Innospec Inc. by 324.5% in Q2, owning 40,120 shares worth $3.37 million. Other investors like Nuveen LLC and Millennium Management LLC also modified their positions. Innospec's stock opened at $75.04, with a market cap of $1.86 billion. Analysts have mixed ratings, with a consensus of "Hold."</p>

Walleye Capital LLC Grows Stock Position in Innospec Inc. $IOSP